New research from UF sheds light on pediatric patient outcomes following proton therapy for ependymoma.

Dr. IndelicatoEpendymoma is one of the most common brain tumors in children under 10 years old. Proton therapy can reduce the low and intermediate radiation dose delivered to uninvolved brain tissue in children with intracranial tumors, which may improve functional outcomes and reduce second malignancies in survivors. Based on this rationale, ependymoma is the most common pediatric tumor treated with proton therapy in the United States.

The authors from the study Outcomes Following Proton Therapy For Pediatric Ependymoma, published last month in Acta Oncologica, report a 3-year survival exceeding 90% in the first 178 children with ependymoma treated with proton therapy at the University of Florida. This series represents the largest single-institution report of intracranial pediatric ependymoma outcomes treated with any radiation modality – proton or x-ray therapy. Therefore it contributes useful information for overall disease management, patient and family counseling, and surveillance guidance for pediatric radiation oncologists worldwide. Moreover, this cohort provides the foundation for continued follow-up studies quantifying the reduction of late toxicity with proton therapy.

“These are encouraging results,” said lead researcher Daniel J. Indelicato, M.D., who holds the Mendenhall Endowed Chair of Pediatric Radiotherapy and serves as associate professor in the UF Department of Radiation Oncology. “We demonstrated that protons are at least as effective as X-rays, in the short term, at reducing the risk of tumor recurrence. Our data further validates the experience reported in smaller groups of patients at other proton therapy centers.”


About This Newsletter

The Precision Newsletter is an electronic-only publication that is distributed by email. Each issue is sent monthly to patients, alumni patients and friends of the University of Florida Health Proton Therapy Institute. As the official newsletter of the Institute, the content is compiled and prepared by our communications representative and approved by the editor Stuart Klein, executive director of UF Health Proton Therapy Institute. Special bulletin newsletters may occasionally be prepared when timely topics and new developments in proton therapy occur. If you would like to send a Letter to the Editor, please click here.


Keep In Touch

It is easy to stay in touch with us online at . Look at the top right corner of the homepage for Facebook , Twitter and YouTube icons, click and join us in the social media conversation. Also on the right side of the homepage there is a button for VTOC Patient Portal . Click here to open your secure account, view your records, complete clinical trial questionnaires and communicate with your nurse case manager.


Knowing how you are feeling during and after treatment is essential to providing you the best care possible and contributes to the care of future patients.